CClinicalTrials.gg
Active, not recruitingNCT07220070Updated Sep 8, 2026

Communication Compass

An interventional study of Algorithm-Based Feedback Reports and Standard Curriculum in Patient Education and Counseling, sponsored by NYU Langone Health. Active, not recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-08.

Sponsored by NYU Langone Health · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Jul 2025, registered Oct 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
138
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The primary purpose of this study is to develop, implement, and validate algorithm-based feedback reports (Communication Compass) that provides personalized, near-real-time feedback on internal medicine residents' patient education and counseling (PEC) communication skills. This research aims to address critical gaps in current communication skills training by leveraging technology to enhance the frequency and specificity of communication skills feedback while maintaining ethical standards and established educational effectiveness.

02

Conditions studied

  • Patient Education and Counseling
03

In context

Lead sponsor

NYU Langone Health is the lead sponsor of 1,391 studies on the registry; 254 are open to participants now.

Of its 227 completed or terminated interventional studies of FDA-regulated products, 191 (84%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Post-graduate year 1 (PGY1) and post-graduate year 2 (PGY2) internal medicine residents enrolled in NYU Langone Health residency programs.
  • Medical school graduates enrolled in ACGME-accredited internal medicine residency programs
  • Residents who routinely participate in required educational activities including OSCEs and clinical assessments

Exclusion criteria

Exclusion Criteria:

  • Individuals who do not meet the criteria established in the 'Inclusion Criteria.'
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
138 participants (actual)

Study arms

  • Experimental
    Intervention Group (Group A)

    Participants assigned to Group A receive algorithm-based feedback reports plus standard curriculum.

    Other: Algorithm-Based Feedback Reports · Other: Standard Curriculum

  • Active comparator
    Control Group (Group B - Delayed Exposure)

    Participants assigned to Group B receive the standard curriculum with usual summary reports. Group members also receive algorithm-based feedback after study completion).

    Other: Standard Curriculum

Interventions

  • OtherAlgorithm-Based Feedback Reports

    Feedback reports that provide personalized, near-real-time feedback on internal medicine residents' patient education and counseling (PEC) communication skills.

  • OtherStandard Curriculum

    Standard summary reports on internal medicine residents' patient education and counseling (PEC) communication skills.

06

What researchers measure

Primary outcomes

  1. Resident Competency

    Percentage of residents rated "well done" on PEC items across all PGY2 Objective Structured Clinical Examination (OSCE) cases.

    Time frame: Up to Year 2

  2. Resident Improvement

    Percentage of residents showing PEC rating improvement from PGY1 to PGY2 OSCE.

    Time frame: Up to Year 1, Up to Year 2

07

Study locations

1 site
  • NYU Langone Health
    New York, New York 10016, United States
08

References and documents

Individual participant data

Plan to share: No — Non-federal sponsor.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07220070
Lead sponsor
NYU Langone Health
Responsible party
Sponsor
First posted
Oct 23, 2025
Start date
Jul 7, 2025
Primary completion
Jun 15, 2027 (estimated)
Completion
Jun 15, 2027 (estimated)
Last update
Sep 8, 2026

Study contacts

Yuliya Yoncheva, PhD
principal investigator · NYU Langone Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion